SEC Info - APP Pharmaceuticals, Inc. - ‘15-12G’ on 9/22/08

APP Pharmaceuticals, Inc. – ‘15-12G’ on 9/22/08

APP Pharmaceuticals, Inc. – ‘15-12G’ on 9/22/08

On: Monday, 9/22/08, at 4:50pm ET · Effective: 9/22/08 · Accession #: 1193125-8-199324 · File #: 0-33407

Certification of Termination of Registration of a Class of Securities — Form 15
Filing Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein

On: Monday, 9/22/08, at 4:50pm ET · Effective: 9/22/08 · Accession #: 1193125-8-199324 · File #: 0-33407

Certification of Termination of Registration of a Class of Securities — Form 15Filing Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein

Certification of Termination of Registration of a Class of Securities — Form 15
Filing Table of Contents

SEC Info℠

Home

Help

Please Sign In

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/22/08  APP Pharmaceuticals, Inc.         15-12G      9/22/08    1:9K                                     RR Donnelley/FA

Document/Exhibit                   Description                      Pages   Size 

 1: 15-12G      Form 15                                             HTML     10K

Form 15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 0-33407

APP Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)

1501 East Woodfield Road, Suite 300 East, Schaumburg, IL 60173-5837. Tel: (847) 969-2700

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, par value $0.001 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:


Rule 12g-4(a)(1)		x
Rule 12g-4(a)(2)		¨
Rule 12h-3(b)(1)(i)		x
Rule 12h-3(b)(1)(ii)		¨
Rule 15d-6		¨

Approximate number of holders of record as of the certification or notice date: 1

Pursuant to the requirements of the Securities Exchange Act of 1934, APP Pharmaceuticals, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

This ‘15-12G’ Filing	Date	Other Filings

Filed on / Effective on:	9/22/08	None on these Dates
		List all Filings

↑Top

Filing Submission 0001193125-08-199324 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Date: September 22, 2008

/s/ Richard Maroun

Name: Richard Maroun

Title: Chief Administrative Officer and General Counsel